Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib
Conditions: NSCLC; BRAF V600E Mutation; Advanced Cancer; Stage IIIB NSCLC; Stage IV NSCLC Intervention: Drug: Combind asprin with Trametinib and Dabrafenib Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials